HIF1A and neoplasm: Preliminary data support the prognostic utility of these biomarkers (41.4% for HIF-1α and 55.2% for c-Myc) for TNBC, being significantly associated with clinical parameters, including tumor size, histological grade, lymph node status, and TNM stage [101].